Researchers sought to determine whether combination decitabine, venetoclax, and ponatinib would be effective in patients with accelerated phase CML.

Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.

Researchers identified risk factors for postoperative nausea and vomiting in patients with lung cancer who underwent thoracoscopic surgery.

Higher Healthy Eating Index score linked to significantly lower risk for grade reclassification in men undergoing active surveillance.

Researchers sought to determine whether a low dose of bosutinib followed by escalation would be effective for patients with CML.

Patients with early breast cancer who are at risk of late relapse after breast-conserving surgery may derive little benefit from adjuvant radiotherapy, research suggests.

Researchers investigated whether naldemedine could help prevent opioid-induced constipation among patients with cancer.

Improved three-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen. HealthDay News — For patients with operative triple-negative breast cancer, a multigene ...

Higher peak doses were associated with inferior progression-free survival and overall survival. Cancer patients may fare better if they receive lower corticosteroid doses to treat immune-related ...

In a review of studies, researchers identified the need for malnutrition screening and recommended 6 validated tools for nutritional assessment in the outpatient setting.

Researchers investigated trends in upper gastrointestinal cancers among young adults analyzed by demographics, histology, and tumor stage.

Decitabine plus venetoclax and ponatinib appeared safe and elicited responses in a phase 2 trial of patients with advanced phase CML.